Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/22/15 → 6/22/18 |
Funding
- Parexel (Prot #R475-PN-1227 // Prot #R475-PN-1227)
- Regeneron Pharmaceuticals, Inc. (Prot #R475-PN-1227 // Prot #R475-PN-1227)
Prot #R475-PN-1227: A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study of the Efficacy and Safety of REGN475 in Patients with Osteoarthritis of the Knee/Hip who have an Inadequate Response to NSAID and Opioid Therapy
- Schnitzer, Thomas J (PD/PI)
Project: Research project